Literature DB >> 24810347

Clostridium difficile spores: a major threat to the hospital environment.

Jonathan Barra-Carrasco1, Daniel Paredes-Sabja.   

Abstract

Clostridium difficile is a Gram-positive, anaerobic spore former and is an important nosocomial and community-acquired pathogenic bacterium. C. difficile infections (CDI) are a leading cause of infections worldwide with elevated rates of morbidity. Despite the fact that two major virulence factors, the enterotoxin TcdA and the cytotoxin TcdB, are essential in the development of CDI, C. difficile spores are the main vehicle of infection, and persistence and transmission of CDI and are thought to play an essential role in episodes of CDI recurrence and horizontal transmission. Recent research has unmasked several properties of C. difficile's unique strategy to form highly transmissible spores and to persist in the colonic environment. Therefore, the aim of this article is to summarize recent advances in the biological properties of C. difficile spores, which might be clinically relevant to improve the management of CDI in hospital environments.

Entities:  

Mesh:

Year:  2014        PMID: 24810347     DOI: 10.2217/fmb.14.2

Source DB:  PubMed          Journal:  Future Microbiol        ISSN: 1746-0913            Impact factor:   3.165


  15 in total

Review 1.  Immune-based treatment and prevention of Clostridium difficile infection.

Authors:  Song Zhao; Chandrabali Ghose-Paul; Keshan Zhang; Saul Tzipori; Xingmin Sun
Journal:  Hum Vaccin Immunother       Date:  2014       Impact factor: 3.452

2.  Screening for potent and selective anticlostridial leads among FDA-approved drugs.

Authors:  Ahmed AbdelKhalek; Haroon Mohammad; Abdelrahman S Mayhoub; Mohamed N Seleem
Journal:  J Antibiot (Tokyo)       Date:  2020-03-04       Impact factor: 2.649

3.  Ultrastructure Variability of the Exosporium Layer of Clostridium difficile Spores from Sporulating Cultures and Biofilms.

Authors:  Marjorie Pizarro-Guajardo; Paulina Calderón-Romero; Daniel Paredes-Sabja
Journal:  Appl Environ Microbiol       Date:  2016-09-16       Impact factor: 4.792

4.  Immunogenicity and protective efficacy of Clostridium difficile spore proteins.

Authors:  Chandrabali Ghose; Ioannis Eugenis; Adrianne N Edwards; Xingmin Sun; Shonna M McBride; David D Ho
Journal:  Anaerobe       Date:  2015-12-11       Impact factor: 3.331

5.  Ultrastructural Variability of the Exosporium Layer of Clostridium difficile Spores.

Authors:  Marjorie Pizarro-Guajardo; Paulina Calderón-Romero; Pablo Castro-Córdova; Paola Mora-Uribe; Daniel Paredes-Sabja
Journal:  Appl Environ Microbiol       Date:  2016-02-05       Impact factor: 4.792

6.  Biocide Resistance and Transmission of Clostridium difficile Spores Spiked onto Clinical Surfaces from an American Health Care Facility.

Authors:  Calie Dyer; Lee P Hutt; Robert Burky; Lovleen Tina Joshi
Journal:  Appl Environ Microbiol       Date:  2019-08-14       Impact factor: 4.792

7.  Immunoinformatics Approach Toward the Introduction of a Novel Multi-Epitope Vaccine Against Clostridium difficile.

Authors:  Caixia Tan; Fei Zhu; Yuanyuan Xiao; Yuqi Wu; Xiujuan Meng; Sidi Liu; Ting Liu; Siyao Chen; Juan Zhou; Chunhui Li; Anhua Wu
Journal:  Front Immunol       Date:  2022-05-26       Impact factor: 8.786

8.  Using bugs as drugs: Microbial ecosystem therapeutics.

Authors:  E Allen-Vercoe; E O Petrof
Journal:  Can Commun Dis Rep       Date:  2015-11-19

9.  Characterization of the Adherence of Clostridium difficile Spores: The Integrity of the Outermost Layer Affects Adherence Properties of Spores of the Epidemic Strain R20291 to Components of the Intestinal Mucosa.

Authors:  Paola Mora-Uribe; Camila Miranda-Cárdenas; Pablo Castro-Córdova; Fernando Gil; Iván Calderón; Juan A Fuentes; Paula I Rodas; Saeed Banawas; Mahfuzur R Sarker; Daniel Paredes-Sabja
Journal:  Front Cell Infect Microbiol       Date:  2016-09-22       Impact factor: 5.293

Review 10.  Disruption of the Gut Microbiome: Clostridium difficile Infection and the Threat of Antibiotic Resistance.

Authors:  Priscilla A Johanesen; Kate E Mackin; Melanie L Hutton; Milena M Awad; Sarah Larcombe; Jacob M Amy; Dena Lyras
Journal:  Genes (Basel)       Date:  2015-12-21       Impact factor: 4.096

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.